Status:

COMPLETED

Oxytocin and Approach-avoid in Grief

Lead Sponsor:

University of Arizona

Conditions:

Prolonged Grief Disorder

Bereavement

Eligibility:

All Genders

55-80 years

Phase:

NA

Brief Summary

This is a completed project which was initiated prior to January 18,2017 Background: Theoretical models of complicated grief (CG) suggest that maladaptive approach (e.g., perseverative proximity-seek...

Eligibility Criteria

Inclusion

  • • Adult individual experiencing death of a spouse or partner between 6 and 36 months prior to enrollment

Exclusion

  • Inability to comprehend English;
  • medical contraindications for other components of the study,
  • active suicidality
  • active homicidality
  • active psychotic symptoms
  • ongoing major health conditions such as cancer; uncontrolled hypertension; and medications likely to impact the oxytocin system (e.g., systemic corticosteroids).
  • pregnant status or suspected pregnant status
  • premenopausal status

Key Trial Info

Start Date :

March 20 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 12 2017

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT04505904

Start Date

March 20 2015

End Date

May 12 2017

Last Update

March 4 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Arizona

Tucson, Arizona, United States, 85721